1. Home
  2. MC vs HALO Comparison

MC vs HALO Comparison

Compare MC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$74.65

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$75.09

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MC
HALO
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
7.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MC
HALO
Price
$74.65
$75.09
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$73.63
$73.33
AVG Volume (30 Days)
772.9K
2.2M
Earning Date
02-04-2026
02-17-2026
Dividend Yield
3.40%
N/A
EPS Growth
446.16
56.68
EPS
3.17
4.74
Revenue
$1,467,580,000.00
$1,242,852,000.00
Revenue This Year
$27.08
$34.83
Revenue Next Year
$17.26
$24.84
P/E Ratio
$24.16
$15.44
Revenue Growth
51.19
31.19
52 Week Low
$47.00
$47.50
52 Week High
$82.89
$79.50

Technical Indicators

Market Signals
Indicator
MC
HALO
Relative Strength Index (RSI) 64.24 72.04
Support Level $68.57 $67.02
Resistance Level $71.78 $69.48
Average True Range (ATR) 1.89 1.85
MACD 0.38 0.92
Stochastic Oscillator 73.71 91.07

Price Performance

Historical Comparison
MC
HALO

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: